Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

Circulating tumor DNA dynamics as an early predictor of recurrence in patients with radically resected colorectal cancer: Updated results from GALAXY study in the CIRCULATE-Japan.

286/2,083 (14%) were ctDNA-positive at the 4-week MRD timepoint and had inferior DFS (HR 12, 95% CI 9.1-15; P<0.0001). Versus patients who stayed negative (n=1,529), conversion from negative to positive (n=112) had HR 14.5 and persistent positivity (n=124) had HR 25.4. Median lead time from ctDNA to radiographic recurrence was 142 days among protocol-imaged recurrences.

ASCO Annual Meeting 2023PubMed 36646802